TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Soflin Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
6,496
|
5,836
|
6,085 |
Financial expenses |
52
|
323
|
164 |
Earnings before taxes |
1,268
|
1,032
|
1,126 |
EBITDA |
1,387
|
1,381
|
1,314 |
Total assets |
4,159
|
2,913
|
3,319 |
Current assets |
2,466
|
1,922
|
1,829 |
Current liabilities |
1,652
|
778
|
1,520 |
Equity capital |
2,246
|
1,860
|
1,583 |
- share capital |
34
|
33
|
36 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
54.0%
|
63.9%
|
47.7% |
Turnover per employee |
3,248
|
2,918
|
3,042 |
Profit as a percentage of turnover |
19.5%
|
17.7%
|
18.5% |
Return on assets (ROA) |
31.7%
|
46.5%
|
38.9% |
Current ratio |
149.3%
|
247.0%
|
120.3% |
Return on equity (ROE) |
56.5%
|
55.5%
|
71.1% |
Change turnover |
631
|
243
|
713 |
Change turnover % |
11%
|
4%
|
13% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.